MARLBOROUGH, Mass., April 14, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will report financial results for the first quarter of 2022 after market close on Thursday, May 5e2022. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.
Investors interested in listening to the conference call can do so by dialing (833) 562-0146 for domestic callers or (661) 567-1226 for international callers, followed by conference ID: 7363649. Live and archived footage of the event will be available in the “Investors” section of Akoya’s website at https://investors.akoyabio.com/.
About Akoya Biosciences
As a space biology society®, Akoya Biosciences’ mission is to put the world of biology and human health into context through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to treatment. Akoya offers a full continuum of spatial phenotyping solutions to meet the diverse needs of researchers in discovery, translational and clinical research through its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Senior Director, Investor Relations
Akoya Biosciences, Inc.